Cargando…
Systemic treatment and targeted therapy in patients with advanced hepatocellular carcinoma
BACKGROUND: Advanced hepatocellular carcinoma (HCC) is a malignancy of global importance: it is the sixth most common cancer and the third most common cause of cancer-related mortality worldwide. Despite decades of efforts by many investigators, systemic chemotherapy or hormone therapy has failed to...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3336907/ https://www.ncbi.nlm.nih.gov/pubmed/22540086 http://dx.doi.org/10.4297/najms.2011.3167 |